BLK vs KALA · P/E 27, rev $24.22B vs $54.3M cap
BlackRock Inc (BLK) versus Kala Pharmaceuticals Inc (KALA) — a side-by-side from cached financials, not a winner call.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
BLK currently screens at market cap $172.19B and trailing P/E 26.6. KALA currently screens at market cap $54.3M.
Not investment advice. Open the BLK and KALA stock pages for the full models.
Not investment advice.